| Company/Division name | Medicines for All Institute |
| Type of work | Manufacturing |
| If manufacturing, is the company a contract manufacturer? | Yes |
| Reshoring category: | Reshoring |
| Year reshoring announced: | 2021 |
| Year reshoring implemented or to be implemented: | 2023 |
| Domestically, the work will be done: | In-house |
| City reshored to: | Petersburg |
| State(s) reshored to: | VA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | pharmaceutical ingredients, sedatives, antibiotics |
| What domestic positive factors made reshoring more attractive? | Government Incentives, Other, import replacement, Covid-19, national stockpile |
| Government Incentive dollar amount: | $354 million |
